Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Hippocampal Temporal Interference Stimulation for Memory and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

8. listopadu 2026 aktualizováno: Jiaojiao Lü, PhD, Shanghai University of Sport

Effects and Underlying Mechanisms of Hippocampal-Targeted Temporal Interference Stimulation on Memory Function and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

This randomized crossover study aims to investigate the immediate effects of hippocampal temporal interference stimulation (TIS) on memory and dual-task postural control in older adults with mild cognitive impairment (MCI).

Participants are assigned to receive three stimulation conditions: 40 Hz TIS, 5 Hz TIS, and sham stimulation. Each condition is administered in a separate session in a randomized order, with at least 7 days between consecutive sessions.

The study compares memory and dual-task postural control across the three stimulation conditions. Memory and dual-task postural control assessments are planned before and after each stimulation session.

Přehled studie

Postavení

Nábor

Podmínky

Intervence / Léčba

Typ studie

Intervenční

Zápis (Odhadovaný)

21

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

  • Jméno: Jiaojiao Lü, PhD
  • Telefonní číslo: +86 18516565889
  • E-mail: ljj27@163.com

Studijní místa

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Čína, 200438
        • Nábor
        • Shanghai University of Sport
        • Kontakt:
          • Ethics Committee of the Shanghai University of Sport
          • Telefonní číslo: +86 21 65508179
          • E-mail: lunli@sus.edu.cn

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

65 let a starší (Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

  1. Age 65 years or older.
  2. Presence of subjective memory complaints.
  3. Objective cognitive impairment, defined as a corrected MoCA-BJ total score of less than 26. The MoCA-BJ has a maximum score of 30. For participants with no more than 12 years of education, 1 point is added to the raw score, and the corrected total score is capped at 30 points.
  4. Global Clinical Dementia Rating (CDR) score of 0.5.
  5. No diagnosis of dementia, with an MMSE score of at least 18 for illiterate participants, at least 21 for those with primary school education, and at least 25 for those with junior high school education or above.
  6. Remains independent in activities of daily living (ADL) and is able to cooperate with all assessments and interventions.

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Crossover Assignment
  • Maskování: Dvojnásobek

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: 40 Hz Temporal Interference Stimulation

Participants receive one 20-minute session of active 40 Hz temporal interference stimulation (TIS) targeting the left hippocampus. In this randomized crossover study, participants are also assigned to receive 5 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 40 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Ostatní jména:
  • TIs
Falešný srovnávač: sham group

Participants receive one 20-minute session of sham temporal interference stimulation (TIS), using the same electrode placement and setup as the 40 Hz TIS session. In this randomized crossover study, participants are also assigned to receive 40 Hz and 5 Hz TIS in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the sham stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Ostatní jména:
  • TIs
Experimentální: 5 Hz Temporal Interference Stimulation

Participants receive one session of active 5 Hz temporal interference stimulation (TIS). In this randomized crossover study, participants are also assigned to receive 40 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 5 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Ostatní jména:
  • TIs

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Accuracy After Stimulation
Časové okno: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized object-scene associative memory task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct match/non-match responses divided by the total number of valid retrieval trials and multiplied by 100. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Reaction Time After Stimulation
Časové okno: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the object-scene associative memory task. Mean reaction time is calculated using valid trials with correct responses. Trials with no response or reaction times shorter than 300 milliseconds are excluded. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Change From Pre-intervention in Word Recognition Accuracy After Stimulation
Časové okno: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized word-recognition task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct responses divided by the total number of analyzed trials and multiplied by 100. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Word Recognition Reaction Time After Stimulation
Časové okno: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the word-recognition task. Mean reaction time is calculated using valid trials with correct responses. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 3-Meter Timed Up and Go Completion Time After Stimulation
Časové okno: Immediately before and after each 20-minute stimulation session during each crossover period

Participants perform the 3-meter Timed Up and Go test under single-task and dual-task conditions. During the dual-task condition, participants complete the test while continuously subtracting 3 from a randomly selected three-digit number. Total completion time is measured in seconds using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean completion time is used. Dual-task cost is calculated as: [(dual-task completion time - single-task completion time) / single-task completion time] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates greater deterioration in mobility performance under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 7-Meter Walking Speed After Stimulation
Časové okno: Immediately before and after each 20-minute stimulation session during each crossover period

Participants complete the 7-meter walking test at their usual comfortable speed under single-task and dual-task conditions. During the dual-task condition, participants walk while continuously subtracting 3 from a randomly selected three-digit number. Walking speed is measured in meters per second using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean walking speed is used. Dual-task cost is calculated as: [(single-task walking speed - dual-task walking speed) / single-task walking speed] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates a greater reduction in walking speed under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Number of Participants With Any Stimulation-Associated Adverse Symptom
Časové okno: During and immediately after each 20-minute stimulation session in each crossover period

Safety is assessed using a standardized adverse-reaction questionnaire completed immediately after each stimulation session. Prespecified symptoms include tingling, itching, burning sensation, pain, skin redness, fatigue, visual sensations, difficulty concentrating, and mood changes. Each symptom is rated as none, mild, moderate, or severe, corresponding to scores of 0, 1, 2, and 3, respectively. Other spontaneously reported symptoms are also recorded. For each stimulation condition, a participant is counted as having an adverse symptom if at least one prespecified or spontaneously reported symptom is present with a severity score of 1 or higher during or immediately after stimulation.

During and immediately after each 20-minute stimulation session in each crossover period

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

30. července 2026

Primární dokončení (Odhadovaný)

15. července 2027

Dokončení studie (Odhadovaný)

30. července 2027

Termíny zápisu do studia

První předloženo

8. srpna 2026

První předloženo, které splnilo kritéria kontroly kvality

13. srpna 2026

První zveřejněno (Aktuální)

18. srpna 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

12. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

8. listopadu 2026

Naposledy ověřeno

1. listopadu 2026

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • ID: 102772026RT090

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NE

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .